Therefore, SGK1 appears to be a malevolent player in the stress response to chemical and radio-therapeutics and might be responsible for a selective advantage that favors uncontrolled cancer progression and selection of the most aggressive clones (89). The gene discussed is SGK1; the disease is cancer.